de Ruiter M - Search Results

1

Belderbos J, Schagen S, Walraven I, Deprez S, de Ruiter M, De Ruysscher D, Le Pechoux C. Belderbos J, et al. Among authors: de ruysscher d, de ruiter m. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):238-239. doi: 10.1016/j.ijrobp.2017.05.012. Epub 2017 Aug 7. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816152 No abstract available.

2

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy.

Kreukels BPC, Hamburger HL, de Ruiter MB, van Dam FSAM, Ridderinkhof KR, Boogerd W, Schagen SB. Kreukels BPC, et al. Among authors: de ruiter mb. Clin Neurophysiol. 2008 Mar;119(3):533-541. doi: 10.1016/j.clinph.2007.11.011. Clin Neurophysiol. 2008. PMID: 18164658 Clinical Trial.

3

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB. de Ruiter MB, et al. Hum Brain Mapp. 2011 Aug;32(8):1206-19. doi: 10.1002/hbm.21102. Epub 2010 Jul 28. Hum Brain Mapp. 2011. PMID: 20669165 Free PMC article.

4

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. de Ruiter MB, et al. Hum Brain Mapp. 2012 Dec;33(12):2971-83. doi: 10.1002/hbm.21422. Epub 2011 Sep 23. Hum Brain Mapp. 2012. PMID: 22095746 Free PMC article.

5

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy.

Koppelmans V, de Ruiter MB, van der Lijn F, Boogerd W, Seynaeve C, van der Lugt A, Vrooman H, Niessen WJ, Breteler MM, Schagen SB. Koppelmans V, et al. Among authors: de ruiter mb. Breast Cancer Res Treat. 2012 Apr;132(3):1099-106. doi: 10.1007/s10549-011-1888-1. Epub 2011 Dec 29. Breast Cancer Res Treat. 2012. PMID: 22205140

6

Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.

Koppelmans V, de Groot M, de Ruiter MB, Boogerd W, Seynaeve C, Vernooij MW, Niessen WJ, Schagen SB, Breteler MM. Koppelmans V, et al. Among authors: de groot m, de ruiter mb. Hum Brain Mapp. 2014 Mar;35(3):889-99. doi: 10.1002/hbm.22221. Epub 2012 Dec 20. Hum Brain Mapp. 2014. PMID: 23281152 Free PMC article.

7

Integrating imaging findings in evaluating the post-chemotherapy brain.

Pomykala KL, de Ruiter MB, Deprez S, McDonald BC, Silverman DH. Pomykala KL, et al. Among authors: de ruiter mb. Brain Imaging Behav. 2013 Dec;7(4):436-52. doi: 10.1007/s11682-013-9239-y. Brain Imaging Behav. 2013. PMID: 23828813 Review.

8

Functional MRI studies in non-CNS cancers.

de Ruiter MB, Schagen SB. de Ruiter MB, et al. Brain Imaging Behav. 2013 Dec;7(4):388-408. doi: 10.1007/s11682-013-9249-9. Brain Imaging Behav. 2013. PMID: 23934234 Review.

9

Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Saykin AJ, de Ruiter MB, McDonald BC, Deprez S, Silverman DH. Saykin AJ, et al. Brain Imaging Behav. 2013 Dec;7(4):363-73. doi: 10.1007/s11682-013-9283-7. Brain Imaging Behav. 2013. PMID: 24327327 Free PMC article.

10

Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type.

Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. Stouten-Kemperman MM, et al. Among authors: de ruiter mb. Brain Imaging Behav. 2015 Jun;9(2):275-84. doi: 10.1007/s11682-014-9305-0. Brain Imaging Behav. 2015. PMID: 24858488 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page